PhRMA members injecting $1.2 trillion into US economy

US lobby group Pharmaceutical Research and Manufacturers of America (PhRMA) revealed that member companies, thanks to President Trump’s new tax law and regulatory streamlining, are investing $500 billion in new USA-based manufacturing and infrastructure, injecting $1.2 trillion into the US economy and creating over 100,000 new jobs, including at least 25,000 direct biopharmaceutical jobs.

Member companies also announced they are providing 10 million patients with financial assistance annually and the creation of AmericasMedicines.com, a search engine to connect patients and businesses with manufacturer direct purchase programs, launching in January 2026.

PhRMA noted that October is Manufacturing Month, and it is a time to recognize the vital role manufacturing plays in America’s economy and global leadership, but also the hard work of the men and women who make it possible. Every year, the American biopharmaceutical industry makes significant investments in manufacturing, a critical component to delivering medicines to patients.